8-K

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM

8-K

CURRENT

REPORT

PURSUANT

TO SECTION 13 OR 15(d) OF THE

SECURITIES

EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): February 1, 2026

---

WELLGISTICS

HEALTH, INC.

(Exact name of registrant as specified in its charter)

Delaware	001-42530	93-3264234
(State<br> or other jurisdiction<br><br> <br>of<br> incorporation)	(Commission<br><br> <br>File<br> Number)	(IRS<br> Employer<br><br> <br>Identification<br> No.)

3000Bayport Drive

Suite950

Tampa,FL 33607

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (844) 203-6092

NotApplicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written<br> communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting<br> material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement<br> communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement<br> communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities

registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common<br> Stock, $0.0001 par value per share	WGRX	The<br> Nasdaq Capital Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements ofCertain Officers.

DirectorResignations

On February 1, 2026, Steven Lee advised the Company that he was resigning from his position as a member of the board of directors effective immediately. Mr. Lee indicated that his decision to resign was not a result of his of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices. At the time of his resignation, Mr. Lee served on the Ethics Committee.

On February 1, 2026, Howard Doss advised the Company that he was resigning from his position as a member of the board of directors effective immediately. Mr. Doss indicated that his decision to resign was not a result of his of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices. At the time of his resignation, Mr. Doss served as chairman on the Audit Committee.

Item9.01. Financial Statements and Exhibits.

---

(d)Exhibits.

The following exhibits are filed as part of, or incorporated by reference into, this Report.

Exhibit No.	Description
17.1	Director Resignation Letter of Steven Lee dated as of February 1, 2026
17.2	Director Resignation Letter of Howard Doss dated as of February 1, 2026
104*	Cover<br> Page Interactive Data File (formatted as Inline XBRL)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:<br> February 5, 2026	WELLGISTICS HEALTH, INC.
	By:	/s/ Prashant Patel
		Prashant<br> Patel, President

Exhibit17.1

BoardResignation

VIA EMAIL

WELLGISTICS HEALTH, INC.

3000 Bayport Drive

Suite 950

Tampa, FL 33607

Re: Resignation from the Board of Directors

Dear Mr. Ajjarapu, Chairman of the Board:

As discussed, I hereby resign from my position as a member of the Board of Directors (the “Board”) of Wellgistics Health, Inc, (the” Company”) and from any committees of the Board on which I serve, including the Governance Committee, effective immediately.

My resignation is not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.

I appreciate the opportunity to have served the Company, and I am grateful to my fellow directors and the management team for their time and collaboration.

Please confirm receipt of this resignation.

Sincerely,

Steven D. Lee

Cc: Members of the Board, Management, and Legal Counsel

Exhibit17.2

DELIVERED VIA EMAIL

February 1, 2026

Wellgistics Health, Inc.

3000 Bayport Drive, Suite 950

Tampa, FL 33607

Re: Resignation from Board of Directors and Committees

Dear Mr. Ajjarapu, Chairman of the Board:

I hereby resign from the Board of Directors of Wellgistics Health, Inc., and from the Audit and Compensation Committees of the Board, effective immediately.

My resignation is not the result of any disagreement with the Company on any matter relating to its operations, policies, or practices.

I appreciate the opportunity to have served the Company and value the professionalism and dedication of my fellow directors and the management team.

Please confirm receipt of this resignation.

Best Regards,

Howard Doss

Cc: Board Members, Management and Legal Counsel